Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis?

Clin Infect Dis. 2013 Aug;57(3):480-1. doi: 10.1093/cid/cit258. Epub 2013 Apr 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / pharmacokinetics
  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / pharmacokinetics
  • Coinfection / drug therapy
  • Drug Interactions*
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Pyrrolidinones / administration & dosage*
  • Pyrrolidinones / pharmacokinetics
  • Raltegravir Potassium
  • Rifampin / administration & dosage*
  • Rifampin / pharmacokinetics
  • Tuberculosis / complications
  • Tuberculosis / drug therapy*

Substances

  • Anti-HIV Agents
  • Antitubercular Agents
  • Pyrrolidinones
  • Raltegravir Potassium
  • Rifampin